Neurogen Corporation
(NASDAQ:NRGN)|
0.10 +0.01 (6.56%) 1:22ET Delayed |
|
|
|
- Compare NRGN with:
- View: Line | Candlestick
Company Profile
Neurogen Corporation
35 Northeast Industrial Road
Branford, CT 06405
United States - Map
Phone: (203) 488-8201
Fax: (203) 481-8683
Website: www.neurogen.com
State of incorporation: Delaware
CEO: Stephen R. Davis, J.D., CPA
Employees: 149
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev/mfr prods for neurological disorders
A drug discovery & development company focusing on new small molecule drugs to improve the lives of patients suffering from disorders with unmet medical need including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrom
Recent news for NRGN
-
EDGAR Online Financials - Nov 18 at 9:04 ET
-
Neurogen Corporation Announces Agreements for Sale of Non-Core Assets for Combined $9 Million
Business Wire - Nov 14 at 7:00 ET
-
NEUROGEN CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 10 at 3:52 ET
-
New Star Analyst Rankings for Neurogen Corporation
StarMine - Nov 10 at 9:21 ET
-
Neurogen Corporation Earnings Call scheduled for 8:30 am ET today
CCBN - Nov 07 at 8:30 ET
-
NEUROGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online - Nov 07 at 7:16 ET
-
Q3 2008 Neurogen Corporation Earnings Release - Before Market Open
CCBN - Nov 07 at 7:07 ET
-
Neurogen Corporation Announces Third Quarter 2008 Financial Results and Updates Operations
Business Wire - Nov 07 at 7:00 ET
-
Neurogen Corporation Earnings Call scheduled for Fri, Nov 7
CCBN - Nov 04 at 3:10 ET
-
Neurogen Corporation Announces Webcast of Third Quarter 2008 Financial Results on November 7, 2008
Business Wire - Nov 04 at 1:00 ET